1. Home
  2. MIRM vs FORM Comparison

MIRM vs FORM Comparison

Compare MIRM & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

SELL

Current Price

$92.00

Market Cap

7.2B

Sector

Health Care

ML Signal

SELL

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

HOLD

Current Price

$83.10

Market Cap

6.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
FORM
Founded
2018
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.4B
IPO Year
2019
2002

Fundamental Metrics

Financial Performance
Metric
MIRM
FORM
Price
$92.00
$83.10
Analyst Decision
Strong Buy
Buy
Analyst Count
12
11
Target Price
★ $157.71
$144.70
AVG Volume (30 Days)
548.2K
★ 1.6M
Earning Date
11-03-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 74.59
N/A
EPS
N/A
★ 1.89
Revenue
★ $19,138,000.00
N/A
Revenue This Year
$37.65
$33.84
Revenue Next Year
$21.04
$24.66
P/E Ratio
★ N/A
$42.95
Revenue Growth
N/A
N/A
52 Week Low
$63.23
$47.33
52 Week High
$130.00
$160.27

Technical Indicators

Market Signals
Indicator
MIRM
FORM
Relative Strength Index (RSI) 52.45 40.00
Support Level $87.38 $69.88
Resistance Level $98.34 $105.71
Average True Range (ATR) 4.20 6.80
MACD 0.35 0.26
Stochastic Oscillator 48.74 35.26

Price Performance

Historical Comparison
MIRM
FORM

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

Share on Social Networks: